Lite Strategy
LITS | NASDAQ
$0.86
+$0.01 (+1.57%)
At close: Nov 16, 2026, 4:00 PM ET
$0.86
$0.00 (-0.41%)
After-hours:
Nov 16, 2026, 4:15 PM ET
+1.57%
(1D)No price chart data available for 1D timeframe.
Rating
25.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #911/1021 (Top 89%)
Key Statistics
Market Data
Market Cap $28.53M
1D Range
0.78 0.90
52W Range
0.74 1.93
Valuation (TTM)
PE -0.11
PB 0.50
EV/EBITDA 4.44
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $0.00
Cash Flow
FCF Yield -23.8%
SBC Adj. FCF Yield -26.0%
SBC Impact -9.2%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y -150.0% |
-64.2%
Dil EPS 3Y | 5Y -9.7% |
-15.7%
FCF 3Y | 5Y 85.7% |
40.0%
Returns
ROA -88.2%
ROE -86.9%
ROIC -20.2%
Financial Health
Net Cash
$4.28M
Current Ratio 3.64
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
Lite Strategy, Inc. functions as a clinical-stage pharmaceutical firm, concentrating its efforts on creating innovative and distinct therapeutic solutions for cancer patients. This entity, which was p...
Sector Healthcare
Industry Biotechnology
Employees 5
IPO Date Dec 18, 2003
Website www.litestrategy.com
Fiscal Year July - June
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove LITS